Loss of caspase-1 and caspase-3 protein expression in human prostate cancer

Cancer Research

Volumn 61, Issue 3, 2001, Pages 1227-1232

  Winter, Rachel N ^a   Kramer, Andrew ^a   Borkowski, Andrew ^a   Kyprianou, Natasha ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; ENZYME PRECURSOR; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER;

BLOTTING, WESTERN; CASPASE 1; CASPASE 3; CASPASE 9; CASPASES; HUMANS; LINEAR MODELS; MALE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0035117041     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cancer statistics
2. The role of androgens in prostatic cancer
3. Ordering the cytochrome c-initiated caspase-cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
4. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
5. Role of apoptosis in development of benign prostatic hyperplasia (BPH) and prostate cancer: Prostate cancer: Clinical significance in diagnosis and treatment
6. Caspases: Enemies within
7. Human ICE/CED-3 protease nomenclature
8. Caspases: The executioners of apoptosis
9. Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7
10. ICE/CED-3 proteases in apoptosis
11. The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling
12. Cytochrome c and dATP-dependent formation of Apaf-1/Caspase-9 complex initiates an apoptotic protease cascade
13. A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes
14. Caspase-9 can be activated without proteolytic processing
15. Autoactivation of procaspase-9 by Apaf-1 mediated oligomerization
16. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP
17. Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: Overexpression of caspase-7 as a new gene therapy strategy for prostate cancer
18. Restoration of transforming growth factor-β signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1 mediated apoptosis
19. Synthesis of pro-caspase-3 and -7 during apoptosis in prostate cancer cells
20. Inhibition of caspases by cytokine response modifier A blocks androgen ablation-mediated prostate cancer cell death in vivo
21. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells
22. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines
23. Sequential dependent enhancement of caspase activation and apoptosis by flavopridol on paclitaxel-treated human gastric and breast cancer cells
24. Overexpression of transforming growth factor (TGF-β) β1 type n receptor restores TGF-β1 sensitivity and signaling in human prostate cancer cells
25. Significance of apoptosis in prostate cancer progression: Relationship with cell proliferation, TGF-β, and bcl-2 expression
26. Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer
27. Immunohistochemical analysis of in vitro patterns of expression of CPP32 (caspase-3), a cell death protease
28. Expression of caspases 3, 6, and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion
29. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
30. 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase
31. Caspase-1 is not involved in experimental hepatitis in mouse
32. The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation
33. Immunohistochemical study of Fas, Fas ligand, and interleukin converting enzyme expression in human prostatic cancer
34. Interleukin 1 and interleukin 1b converting enzyme (caspase-1) expression in the human colonic epithelial barrier: Caspase-1 downregulation in colon cancer
35. Interleukin 1β-converting enzyme (caspase-1) is overexpressed in the adenocarcinoma of the pancreas
36. Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies
37. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
38. Involvement of caspases in proteolytic cleavage of Alzheimer's Amyloid β precursor protein and myloidogenic Aβ peptide formation
39. Immunohistochemical analysis of interleukin-1b converting enzyme/Ced-3 family protease. CPP32/Yama/caspase-3, in Hodgkin's disease
40. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (caspase-3) in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes
41. Immunohistuchemical localization of caspase-3 correlates with clinical outcome in B-cell diffuse large-cell lymphoma